Immunisation policy and governance
Some key groups advise the Australian Government on immunisation policy and regulations.
Advice from experts helps ensure good policy, governance and regulation about immunisation. Some key groups advise the Australian Government on immunisation and assist in making new vaccines available under the National Immunisation Program (NIP).
Office of Health Protection
The Office of Health Protection (OHP), in partnership with key stakeholders, works to protect the health of Australians. OHP is a division within the Department of Health responsible for managing immunisation programs and policies in line with the Government's preventive health framework. The key priorities of the OHP are to:
- implement the NIP
- make sure essential vaccines for the NIP are available
- develop immunisation policy
- provide technical advice on immunisation
- liaise with the Therapeutic Goods Association (TGA) on the use of vaccines.
Find out more about the OHP.
Australian Technical Advisory Group on Immunisation
The Australian Technical Advisory Group on Immunisation (ATAGI) advises the Minister for Health on the NIP and other issues. In addition to technical experts, the Group’s membership includes a consumer representative, a nurse and general practitioners.
Find out more about the ATAGI.
National Immunisation Committee
The National Immunisation Committee (NIC) provides strategic advice on the NIP and represents the needs and views of vaccination providers and consumers.
The Committee reports to the Australian Health Protection Principal Committee (AHPPC) through the Communicable Diseases Network Australia (CDNA).
Find out more about the NIC.
Therapeutic Goods Administration
The Therapeutic Goods Administration (TGA) works to protect the health of the Australian community through the regulation of therapeutic goods, including vaccines.
Find out more about the TGA.
Advisory Committee on Vaccines
The Advisory Committee on Vaccines (ACV) provides independent medical and scientific advice to the Minister for Health and the TGA. Its advice focuses on the safety, quality and effectiveness of vaccines supplied in Australia.
Find out more about the ACV.
National Health and Medical Research Council
The National Health and Medical Research Council (NHMRC) provides funding for research to improve medical treatment and the health outcomes of Australians, including the approval of the Australia Immunisation Handbook.
Find out more about the NHMRC.
Process for listing new vaccines on the NIP
A number of steps need to occur before a vaccine becomes available on the NIP, including:
- registration of the vaccine by the TGA
- a positive recommendation by the Pharmaceutical Benefits Advisory Committee
- a price agreement between the Department of Health and the pharmaceutical company
- Government approval
- changes to relevant laws
- purchase of the vaccine.
Find out more about the process for listing new vaccines.